(Ebook) Plunkett's Biotech & Genetics Industry Almanac 2013: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies by Jack W. Plunkett, Jack W. Plunkett ISBN 9781608796830, 1608796833

(Ebook) Plunkett's Biotech & Genetics Industry Almanac 2013: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies by Jack W. Plunkett, Jack W. Plunkett ISBN 9781608796830, 1608796833

PLUNKETT'S BIOTECH & GENETICS INDUSTRY ALMANAC 2013Key Features:•Industry trends analysis, market data and competitive intelligence•Market forecasts and Industry Statistics•Industry Associations and Professional Societies List•In-Depth Profiles of hundreds of leading companies•Industry Glossary•Buyer may register for access to search and export data at Plunkett Research OnlinePages: 537Statistical Tables Provided: 18Companies Profiled: 353Geographic Focus: GlobalA complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms. You will gain vital insights that can help you shape your own strategy for business development, product development and investments. •How is the industry evolving? •How is the industry being shaped by new technologies? •How is demand growing in emerging markets and mature economies?•What is the size of the market now and in the future?•What are the financial results of the leading companies?•What are the names and titles of top executives?•What are the top companies and what are their revenues? Contents, Statistics, Forecasts and Analysis Include:Major Trends Affecting the Biotech & Genetics Industry1)The State of the Biotechnology Industry Today 2)A Short History of Biotechnology 3)Ethanol Production Soars, But U.S. Federal Subsidy in Question 4)Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms 5)From India to Singapore to China, Nations Compete Fiercely in Biotech Development 6)Clinical Trials and Medical Records Processing Conducted Abroad Spark Concerns 7)Gene Therapies and Patients Genetic Profiles Promise a Personalized Approach to Medicine 8)Breakthrough Drugs for Cancer Treatment Many More Will Follow 9)Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues 10)Biotech and Orphan Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age 11)Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce 12)Breakthrough New Drug Delivery Systems Evolve 13)Stem Cells Multiple Sources Stem from New Technologies 14)Government Support for Stem Cell Research Evolves 15)Stem Cells Therapeutic Cloning Techniques Advance 16)Stem Cells A New Era of Regenerative Medicine Takes Shape 17)Nanotechnology Converges with Biotech 18)Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/Selective Breeding Offers a Compromise 19)Focus on Vaccines 20)Technology Discussion Genomics 21)Technology Discussion Proteomics 22)Technology Discussion Microarrays 23)Technology Discussion DNA Chips24)Technology Discussion SNPs ( Snips ) 25)Technology Discussion Combinatorial Chemistry 26)Technology Discussion Synthetic Biology27)Technology Discussion Recombinant DNA28)Technology Discussion Polymerase Chain Reaction (PCR)Biotech & Genetics Industry Statistics 1)Biotech Industry Overview 2)The U.S. Drug Discovery & Approval Process 3)U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 20114)U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals:1993-2011 5)Employment in Life & Physical Science Occupations, U.S.: May 2011 6)Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2011-2013 7)U.S. Exports & Imports of Pharmaceutical Products: 2007-1st Quarter 2012 8)U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: 2006-2021